Journal of the Neurological Sciences
Volume 298, Issue 1 , Pages 96-100 , 15 November 2010

Epistasis between HLA-DRB1 parental alleles in a Spanish cohort with multiple sclerosis

  • Lucía Romero-Pinel

      Affiliations

    • Multiple Sclerosis Unit, Neurology Department, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain
    • ,
  • Josep María Pujal

      Affiliations

    • Multiple Sclerosis Unit, Neurology Department, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain
    • ,
  • Sergio Martínez-Yélamos

      Affiliations

    • Multiple Sclerosis Unit, Neurology Department, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain
    • ,
  • Laura Gubieras

      Affiliations

    • Multiple Sclerosis Unit, Neurology Department, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain
    • ,
  • Elisabet Matas

      Affiliations

    • Multiple Sclerosis Unit, Neurology Department, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain
    • ,
  • Laura Bau

      Affiliations

    • Multiple Sclerosis Unit, Neurology Department, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain
    • ,
  • Marta Torrabadella

      Affiliations

    • Banc de Cordó Umbilical, Banc de Sang i Teixits, Barcelona, Spain
    • ,
  • Carmen Azqueta

      Affiliations

    • Banc de Cordó Umbilical, Banc de Sang i Teixits, Barcelona, Spain
    • ,
  • Txomin Arbizu

      Affiliations

    • Multiple Sclerosis Unit, Neurology Department, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain
    • Corresponding Author InformationCorresponding author. Multiple Sclerosis Unit, Neurology Department, Hospital Universitari de Bellvitge, Gran Vía s/n, km 2,7, Hospital Duran i Reynals, 08907 L'Hospitalet de Llobregat, Barcelona, Spain. Tel.: +34 93 2607813; fax: +34 93 2607778.

Received 1 June 2010 ,Revised 26 July 2010 ,Accepted 29 July 2010.

References 

  1. Ramagopalan SV, Ebers GC. Epistasis: multiple sclerosis and the major histocompatibility complex. Neurology. 2009;72:566–567
  2. Dyment DA, Ebers GC, Sadovnick AD. Genetics of multiple sclerosis. Lancet Neurol. 2004;3:104–110
  3. Schmidt H, Williamson D, Ashley-Koch A. HLA-DR15 haplotype and multiple sclerosis: a HuGE review. Am J Epidemiol. 2007;165:1097–1109
  4. Chao MJ, Barnardo MC, Lincoln MR, Ramagopalan SV, Herrera BM, Dyment DA, et al. HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility. Proc Natl Acad Sci U S A. 2008;105:13069–13074
  5. Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, De Jager PL, et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med. 2007;357:851–862
  6. Sawcer S. The complex genetics of multiple sclerosis: pitfalls and prospects. Brain. 2008;131:3118–3131
  7. Baranzini SE, Wang J, Gibson RA, Galwey N, Naegelin Y, Barkhof F, et al. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet. 2009;18:767–778
  8. Fernández O, Fernández V, Alonso A, Caballero A, Luque G, Bravo M, et al. DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain. J Neurol. 2004;251:440–444
  9. Lincoln MR, Ramagopalan SV, Chao MJ, Herrera BM, Deluca GC, Orton SM, et al. Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility. Proc Natl Acad Sci USA. 2009;106:7542–7547
  10. DeLuca GC, Ramagopalan SV, Herrera BM, Dyment DA, Lincoln MR, Montpetit A, et al. An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus. Proc Natl Acad Sci U S A. 2007;104:20896–20901
  11. Ramagopalan SV, Morris AP, Dyment DA, Herrera BM, DeLuca GC, Lincoln MR, et al. The inheritance of resistance alleles in multiple sclerosis. PLoS Genet. 2007;3:1607–1613
  12. Dyment DA, Herrera BM, Cader MZ, Willer CJ, Lincoln MR, Sadovnick AD, et al. Complex interaction among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum Mol Genet. 2005;14:2019–2026
  13. Wu JS, Qiu W, Castley A, James I, Mastaglia FL, Christiansen FT, et al. Modifying effects of HLA-DRB1 allele interactions on age at onset of multiple sclerosis in Western Australia. Mult Scler. 2010;16:15–20
  14. Wu JS, Qiu W, Castley A, James I, Joseph J, Christiansen FT, et al. Presence of CSF oligoclonal bands (OCB) is associated with the HLA-DRB1 genotype in a West Australia multiple sclerosis cohort. J Neurol Sci. 2010;288:63–67
  15. Confavreux C, Compston DA, Hommes OR, McDonald WI, Thompson AJ. EDMUS, a European database for multiple sclerosis. J Neurol Neurosurg Psychiatry. 1992;55:671–676
  16. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol. 2005;58:840–846
  17. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996;46:907–911
  18. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444–1452
  19. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2hours: an alternative serological DR typing in clinical practice including donor–recipient matching in cadaveric transplantation. Tissue Antigens. 1992;39:225–235
  20. Romero-Pinel L, Pujal JM, Martínez-Yélamos S, Gubieras L, Matas E, Bau L, et al. HLA-DRB1: genetic susceptibility and disability progression in a Spanish multiple sclerosis population. Eur J Neurol in press, doi:10.1111/j.1468-1331.2010.03148.x.
  21. Barcellos LF, Sawcer S, Ramsay PP, Baranzini SE, Thomson G, Briggs F, et al. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet. 2006;15:2813–2824
  22. Silva AM, Pereira C, Bettencourt A, Carvalho C, Couto AR, Leite MI, et al. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese multiple sclerosis population. J Neurol Sci. 2007;258:69–74
  23. Weatherby SJ, Thomson W, Pepper L, Donn R, Worthington J, Mann CL, et al. HLA-DRB1 and disease outcome in multiple sclerosis.. J Neurol. 2001;248:304–310
  24. Stankovich J, Butzkueven H, Marriott M, Chapman C, Tubridy N, Tait BD, et al. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis. Tissue Antigens. 2009;74:17–21
  25. Marrosu MG, Murru MR, Costa G, Murru R, Muntoni F, Cucca F. DRB1, DQA1-DQB1 loci and multiple sclerosis predisposition in Sardinian population. Hum Mol Genet. 1998;7:1235–1237
  26. Saruhan-Direskeneli G, Esin S, Baykan-Kurt B, Ornek I, Vaughan R, Eraksoy M. HLA-DR and -DQ associations with multiple sclerosis in Turkey. Hum Immunol. 1997;55:59–65
  27. Coraddu F, Reyes-Yanez MP, Parra A, Gray J, Smith SI, Taylor CJ, et al. HLA associations with multiple sclerosis in the Canary Islands. J Neuroimmunol. 1998;87:130–135
  28. Barcellos LF, Oksenberg JR, Begovich AB, Martin ER, Schmidt S, Vittinghoff E, et al. HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am J Hum Genet. 2003;72:710–716
  29. Ballerini C, Guerini FR, Rombolà G, Rosati E, Massacesi L, Ferrante P, et al. HLA-multiple sclerosis association in Continental Italy and correlation with disease prevalence in Europe. J Neuroimmunol. 2004;150:178–185
  30. Fernández O, R-Antigüedad A, Pinto-Medel MJ, Mendibe MM, Acosta N, Oliver B, et al. HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain). J Neurol. 2009;256:1977–1988
  31. Masterman T, Ligers A, Olsson T, Andersson M, Olerup O, Hillert J. HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol. 2000;48:211–219
  32. Wu JS, James I, Qiu W, Castley A, Christiansen FT, Carroll WM, et al. HLA-DRB1 allele heterogeneity influences multiple sclerosis severity as well as risk in Western Australia. J Neuroimmunol. 2010;219:109–113
  33. Hensiek AE, Sawcer SJ, Feakes R, Deans J, Mander A, Akesson E, et al. HLA-DR15 is associated with female sex and younger age at diagnosis in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2002;72:184–187
  34. Cournu-Rebeix I, Génin E, Leray E, Babron MC, Cohen J, Gout C, et al. HLA-DRB1*15 allele influences the later course of relapsing remitting multiple sclerosis. Genes Immun. 2008;9:570–574
  35. Vasconcelos CC, Fernández O, Leyva L, Thuler LC, Alvarenga RM. Does the DRB1*1501 allele confer more severe and faster progression in primary progressive multiple sclerosis patients? HLA in primary progressive multiple sclerosis. J Neuroimmunol. 2009;214:101–103
  36. Okuda DT, Srinivasan R, Oksenberg JR, Goodin DS, Baranzini SE, Beheshtian A, et al. Genotype–phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures. Brain. 2009;132:250–259

PII: S0022-510X(10)00349-7

doi: 10.1016/j.jns.2010.07.026

Journal of the Neurological Sciences
Volume 298, Issue 1 , Pages 96-100 , 15 November 2010

Article Tools

* Image Usage & Resolution